CHMP extends immunisation period for Rotateq
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's scientific committee, the CHMP, in its meetings of 16-19 January 2012 recommended a variation on the indication for Sanofi Pasteur's rotavirus vaccine, Rotateq.